Clinical benefit as a primary efficacy endpoint [5]

Journal of Clinical Oncology

Volumn 16, Issue 2, 1998, Pages 803-804

  Ballatori, Enzo ^a   Del Favero, Albano ^a   Roila, Fausto ^a  

^a UNIVERSITY OF L'AQUILA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; GEMCITABINE; OPIATE; STEROID;

ANALGESIA; CANCER PAIN; CLINICAL TRIAL; DRUG EFFICACY; FEVER; HUMAN; LETTER; NEUTROPENIA; PANCREAS CANCER; PRIORITY JOURNAL; QUALITY OF LIFE; RISK BENEFIT ANALYSIS; TREATMENT OUTCOME;

EID: 0031916322     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1998.16.2.803     Document Type: Letter

References (3)